BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services. | ![]() ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. | Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. | ![]() Azenta Life Sciences Azenta Life Sciences (formerly known as Brooks Automation) is a provider of biological and chemical compound sample exploration and management capabilities for the life sciences industry. | ||
Founding Date | Founding Date 1999 | Founding Date 2014 | Founding Date 1998 | Founding Date 1978 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations San Diego, US HQ Melbourne, AU Wien, AT Mechelen, BE Sao Paulo, BR Vancouver, CA Beijing, CN see more | Locations Burlington, US HQ Beijing, CN Guangzhou, CN Shanghai, CN Shanghai, CN Suzhou, CN Tianjin, CN see more | Locations Lund, SE HQ |
Employees | Employees 3,702 | Employees 1,869 | Employees 8,6004% decrease | Employees 3,5009% increase | Employees 902% decrease |
Valuation ($) | Valuation ($) 2.7 b | Valuation ($) 3.2 b | Valuation ($) 23.3 b | Valuation ($) 2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥3.7b (FY, 2025) | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) $593.8m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥2.3b (FY, 2025) | Cost of goods $190.5m (FY, 2025) | Cost of goods $1.5b (FY, 2025) | Cost of goods $323.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥1.4b (FY, 2025) | Gross profit $269.6m (FY, 2025) | Gross profit $2.9b (FY, 2025) | Gross profit $270.3m (FY, 2025) | Gross profit N/A |
Net income | Net income (¥637.8m) (FY, 2025) | Net income ($175.5m) (FY, 2025) | Net income $850m (FY, 2025) | Net income ($55.8m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries 100 (FY, 2022) | Countries N/A | Countries N/A | Countries 180 (Q1, 2023) | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 985m | Total funding raised $ 28m | Total funding raised N/A | Total funding raised $ 5.5m |

Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
View companyIllumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis.
View company
Azenta Life Sciences (formerly known as Brooks Automation) is a provider of biological and chemical compound sample exploration and management capabilities for the life sciences industry.
View company
SAGA Diagnostics is a personalized cancer medicine and disease monitoring company.
View company